Alfonso Salas Clinica Glendale, AZ - 85301

Alfonso Salas Clinica is categorized under Employment Agencies and Opportunities in Glendale, AZ and active since 2004.

Alfonso Salas Clinica was established in 2004, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Employment Agencies and Opportunities business, which does work in the B2B market, and is classified as a Employment Agencies and Opportunities, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Jorge Escalante at the company’s single location by writing to 7734 North 59th Avenue, Glendale, Arizona AZ 85301 or by phoning (623) 931-2759. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Alfonso Salas Clinica
Contact Person: Jorge Escalante
Address: 7734 North 59th Avenue, Glendale, Arizona 85301
Phone Number: (623) 931-2759
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Employment Agencies and Opportunities
SIC Code: 7361
NAICS Code: 6211110
Share This Business:

Alfonso Salas Clinica was started in 2004 to provide professional Employment Agencies and Opportunities under the SIC code 7361 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Jorge Escalante for inquiries that concern Alfonso Salas Clinica by calling the company number (623) 931-2759, as your correspondence is most welcome. Additionally, the physical location of the single location of Alfonso Salas Clinica can be found at the coordinates 33.55004,-112.18622 as well as the street address 7734 North 59th Avenue in Glendale, Arizona 85301.

For its online presence, you may visit Alfonso Salas Clinica’s website at and engage with its social media outlets through on Twitter and on Facebook.